Last $20.18 USD
Change Today +0.02 / 0.10%
Volume 1.0M
AMED On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

amedisys inc (AMED) Snapshot

Open
$19.76
Previous Close
$20.16
Day High
$20.35
Day Low
$19.03
52 Week High
07/30/14 - $20.93
52 Week Low
11/13/13 - $12.60
Market Cap
670.7M
Average Volume 10 Days
619.8K
EPS TTM
$-0.19
Shares Outstanding
33.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMEDISYS INC (AMED)

amedisys inc (AMED) Related Businessweek News

View More BusinessWeek News

amedisys inc (AMED) Details

Amedisys Inc. provides home health and hospice services including practical nursing services and physical and occupational therapy. The company’s services also comprise speech pathology, social work to help families address acute and chronic illnesses, home health aide services, and private duty services. Hospice services use a team made up of a physician, patient care manager, registered nurses, certified home health aides, social workers, a chaplain, a homemaker, and volunteers. As of Apr. 4, 2007, the company operated 261 Medicare-certified home health agencies and 14 Medicare-certified hospice agencies in 19 states. Amedisys was founded in 1982 and is headquartered in Baton Rouge, La.

14,300 Employees
Last Reported Date: 03/12/14
Founded in 1982

amedisys inc (AMED) Top Compensated Officers

Interim Chief Executive Officer, President an...
Total Annual Compensation: $514.2K
Chief Medical Officer
Total Annual Compensation: $308.5K
Senior Vice President, General Counsel and Co...
Total Annual Compensation: $277.3K
Chief Compliance Officer
Total Annual Compensation: $270.6K
Compensation as of Fiscal Year 2013.

amedisys inc (AMED) Key Developments

Amedisys Inc. Reports Unaudited Consolidated Financial Results for the Second Quarter and Six Months Ended June 30, 2014; Records Other Intangibles Impairment Charge for the Second Quarter Ended June 30, 2014

Amedisys Inc. reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net service revenue was $305,006,000 against $315,960,000 for the same period last year. Operating income was $12,561,000 against $4,250,000 for the same period last year. Income before income taxes was $12,353,000 against $3,047,000 for the same period last year. Income from continuing operations was $7,610,000 or $0.23 diluted per share against $2,005,000 or $0.06 diluted per share for the same period last year. Net income attributable to Amedisys Inc. was $7,619,000 or $0.23 diluted per share against $1,841,000 or $0.06 diluted per share for the same period last year. Net cash used in operating activities was $89,129,000 compared with net cash provided by operating activities of $33,561,000 for the same period last year. EBITDA was $21,329,000 against $13,454,000 for the same period last year. Adjusted EBITDA was $22,113,000 against $19,587,000 for the same period last year. Adjusted net income from continuing operations attributable to Amedisys Inc. was $8,040,000 or $0.25 diluted per share against $5,775,000 or $0.18 diluted per share for the same period last year. For the six months, the company reported net service revenue was $603,745,000 against $644,562,000 for the same period last year. Operating loss was $7,012,000 against operating income of $9,617,000 for the same period last year. Loss before income taxes was $7,498,000 against income before income taxes of $8,055,000 for the same period last year. Loss from continuing operations was $4,623,000 or $0.14 diluted per share against income from continuing operations of $4,862,000 or $0.17 diluted per share for the same period last year. Net loss attributable to Amedisys Inc. was $4,798,000 or $0.15 diluted per share against net income attributable to Amedisys Inc. of $4,519,000 or $0.14 diluted per share for the same period last year. Net cash used in operating activities was $95,471,000 compared with net cash provided by operating activities of $65,977,000 for the same period last year. EBITDA was $10,728,000 against $29,759,000 for the same period last year. Adjusted EBITDA was $27,612,000 against $37,923,000 for the same period last year. Adjusted net income from continuing operations attributable to Amedisys Inc. was $5,818,000 or $0.18 diluted per share against $10,429,000 or $0.33 diluted per share for the same period last year. The company recorded other intangibles impairment charge of $2,286,000 compared with $1,408,000 for the same period last year.

Amedisys Inc. Announces New $70 Million Second Lien Credit Facility and Amendment to Senior Secured Credit Facility

Amedisys Inc. announced that it entered into a new $70 million six-year second lien term loan facility. In connection with the new second lien facility, the company's existing senior secured credit facility was amended and downsized to $159 million, consisting of an existing term loan with a balance of $39 million and a $120 million revolving credit facility. The maturity of the senior secured facility will remain unchanged. Proceeds from the new term loan were used to pay down outstanding revolver balances. The interest rate of the second lien term loan is priced at LIBOR plus 7.5% with a 1.0% LIBOR floor.

Amedisys Inc. to Report Q2, 2014 Results on Jul 30, 2014

Amedisys Inc. announced that they will report Q2, 2014 results on Jul 30, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMED:US $20.18 USD +0.02

AMED Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Almost Family Inc $23.44 USD -0.15
BioScrip Inc $7.49 USD -0.13
Chemed Corp $101.85 USD -0.59
Gentiva Health Services Inc $18.10 USD -0.05
LHC Group Inc $23.48 USD +1.19
View Industry Companies
 

Industry Analysis

AMED

Industry Average

Valuation AMED Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.5x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMEDISYS INC, please visit www.amedisys.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.